Hereditary cancer disorders often provide an important window into novel mechanisms supporting tumor growth. Understanding these mechanisms thus represents a vital goal. Toward this goal, here we report a chemoproteomic map of fumarate, a covalent oncometabolite whose accumulation marks the genetic cancer syndrome hereditary leiomyomatosis and renal cell carcinoma (HLRCC). We applied a fumarate-competitive chemoproteomic probe in concert with LC-MS/MS to discover new cysteines sensitive to fumarate hydratase (FH) mutation in HLRCC cell models. Analysis of this dataset revealed an unexpected influence of local environment and pH on fumarate reactivity, and enabled the characterization of a novel FH-regulated cysteine residue that lies at a key protein-protein interface in the SWI-SNF tumor-suppressor complex. Our studies provide a powerful resource for understanding the covalent imprint of fumarate on the proteome and lay the foundation for future efforts to exploit this distinct aspect of oncometabolism for cancer diagnosis and therapy.
A major finding of modern cancer genomics has been the discovery of driver mutations in primary metabolic enzymes [1] [2] [3] . Many of these lesions cause the accumulation of 'oncometabolites' , endogenous metabolites whose accretion can directly drive malignant transformation. For example, mutation of fumarate hydratase (FH) in the familial cancer syndrome hereditary leiomyomatosis and renal cell carcinoma (HLRCC) leads to high levels of intracellular fumarate 4, 5 . Fumarate has been hypothesized to promote tumorigenesis both by reversibly inhibiting dioxygenases involved in epigenetic signaling 6, 7 and by interacting with proteins covalently as an electrophile, forming the nonenzymatic post-translational modification cysteine S-succination ( Fig. 1a) 8 . This latter mechanism is unique to fumarate and has been proposed to contribute to the distinct tissue selectivity, gene expression profiles, and clinical outcomes observed in HLRCC relative to other oncometabolite-driven cancers 9, 10 . Consistent with a functional role, studies have found that S-succination of Keap1 can activate NRF2-mediated transcription in HLRCC 11 . Furthermore, global immunohistochemical staining of S-succination has been applied to assess stage and progression of FH-deficient tumors, suggesting the utility of this modification as a biomarker 12 .
Despite its potential relevance to HLRCC pathology, our overall understanding of fumarate's covalent reactivity remains incomplete. Our current knowledge of S-succination is limited to proteins identified by candidate methods, such as Keap1 (ref. 11 ), or whole-proteome mass spectrometry [13] [14] [15] . Neither of these approaches report on the extent of S-succination, impeding our ability to decipher what structural features drive fumarate's reactivity and whether these modifications alter protein function. A better understanding of the global scope and stoichiometry of fumarate reactivity has the potential to deliver new insights into HLRCC biology and provide site-specific biomarkers for assessing tumor development and therapeutic response.
Toward this goal, here we report a chemoproteomic map of the covalent targets of the oncometabolite fumarate. First, we establish the utility of chemoproteomic probes to compete for occupancy of fumarate-reactive cysteines. Next, we apply these probes in combination with quantitative mass spectrometry to define the proteome-wide sensitivity of cysteine residues to FH mutation. Functional analysis of this dataset led to the discovery of new molecular determinants of fumarate sensitivity and the characterization of a FH-sensitive cysteine in SMARCC1, a member of the SWI-SNF tumor-suppressor complex. By establishing a new resource for understanding how fumarate reactivity impacts HLRCC biology, our studies provide an essential underpinning for applications seeking to exploit this unique aspect of oncometabolism for clinical benefit.
Results
Comparative affinity profiling of fumarate reactivity. Several recent studies have demonstrated the utility of competitive chemoproteomics to characterize electrophilic drug targets 16, 17 . To extend these methods to an endogenous oncometabolite, we first characterized fumarate's reactivity profile. Several pieces of evidence suggest that fumarate may exhibit fairly modest reactivity. Most relevantly, studies of the multiple sclerosis drug dimethyl fumarate (Tecfidera; DMF) found that its metabolized product monomethyl fumarate (MMF) possesses limited thiol reactivity at micromolar Articles NATURe CHeMICAL BIOLOgy concentrations 18, 19 . Theoretical calculations indicate that this stems from MMF's higher lying LUMO (lowest unoccupied molecular orbital), which increases the energetic barrier to covalent bond formation with nucleophilic cysteines 18 . Fumarate's LUMO is even higher in energy than MMF ( Supplementary Fig. 1a ), suggesting that it may possess a distinct reactivity profile. However, the relative reactivity of the drug and oncometabolite have never been directly assessed.
To explore this, we treated HEK-293 cell extracts with increasing amounts of fumarate and analyzed proteomes for covalent labeling using an S-succination antibody (Fig. 1b ). An equivalent amount of HLRCC proteome (UOK262, FH −/− ) was used to compare levels of S-succination caused by FH mutation. Fumarate proved to be a relatively mild electrophile, requiring millimolar concentrations to cause S-succination equivalent to HLRCC proteomes ( Fig. 1b ; Supplementary Fig. 1b ) 5 . We validated this finding using a clickable chemotype mimic fumarate alkyne (FA-alkyne, 1; Fig. 1c ). FA-alkyne is more reactive than fumarate because of the analog's lower lying LUMO ( Supplementary Fig. 1c ). However, consistent with covalent labeling via Michael addition, we observed timeand dose-dependent protein labeling of lysates by FA-alkyne, but not an inert succinate analog ( Supplementary Fig. 1d,e ). Although FA-alkyne labeling was modestly competed by fumarate, it was completely abrogated by pre-incubation with MMF, DMF, and iodoacetamide, again highlighting the attenuated reactivity of the oncometabolite relative to conventional electrophiles ( Supplementary Fig. 1f ,g). Low millimolar concentrations of fumarate also impeded cysteine labeling by the established chemoproteomic reagent iodoacetamide alkyne (IA-alkyne, 2; Fig. 1d ) 16 . Pretreatment of lysates with iodoacetamide reciprocally inhibited fumarate-dependent S-succination, confirming that these chemotypes compete for cysteine occupancy ( Supplementary Fig. 1h ). These results highlight the distinct reactivity of fumarate relative to DMF and MMF and suggest that this metabolite's reactivity may be most relevant in pathophysiological contexts such as HLRCC in which it accumulates to millimolar levels.
Global chemoproteomic profiling of FH-regulated cysteines.
The distinct reactivity of fumarate suggests that its accumulation in HLRCC may impart a unique covalent imprint on the proteome. To characterize this effect, we applied IA-alkyne and an LC-MS/MS platform derived from isoTOP-ABPP to map cysteine reactivity changes caused by a FH mutation ( Fig. 2a) 20 . Briefly, proteomes were isolated from an immortalized HLRCC cell line (UOK262 FH −/− ) and a rescue line in which re-introduction of FH gene reduces S-succination (UOK262WT, FH +/+ ; Fig. 2b ) 21 . Paired samples from FH −/− and FH +/+ cells were treated with IA-alkyne, conjugated to isotopically distinguishable azide-biotin tags using click chemistry, pooled, and enriched over streptavidin. Following on-bead tryptic digest, IA-alkyne labeled peptides were released by dithionite cleavage of an azobenzene linker. LC-MS/MS was used to identify Cyscontaining peptides, with the relative intensity ratio (R) of light/heavy (L/H) isotopic pairs in the MS1 spectra used as a quantitative readout of relative Cys-labeling stoichiometry ( Fig. 2a ). R values of ~1 indicate that a cysteine was unaffected by FH mutation, whereas an R value of 2 indicates a cysteine's reactivity (or abundance) is reduced ~50% by FH mutation (based on the formula 'relative modification stoichiometry (%) = [1 − (1/R)] × 100%'; Fig. 2a ). One critical feature of this experiment is that it is mechanism agnostic, and as such may identify FHregulated cysteine reactivity changes caused by direct S-succination as well as alternative stimuli such as altered gene expression or oxidative stress (notably, our culture media contained pyruvate, which limits reactive oxygen species in HLRCC cells) 9, 10, 22 . We thus term these differentially occupied residues 'FH-regulated' cysteines.
Applying this approach, we performed three independent replicate measurements of cysteine reactivity in HLRCC cells, leading to the quantification of 1,170 cysteine residues ( Fig. 2c , Supplementary Dataset 1). This data can be searched via the web at https://ccr2.cancer.gov/resources/Cbl/proteomics/fumarate. Application of reproducibility metrics (identified in ≥ 2 datasets, R s.d. ≤ 25%) led to the further specification of 684 high-confidence FH-regulated cysteines. The reactivity of 105 cysteines was upregulated ≥ 2-fold by FH rescue, consistent with reduced S-succination or oxidation in FH +/+ cells ( Fig. 2c , Supplementary Dataset 1). Identified among these hits were 28 known targets of S-succination including ACO2 (ref. 15 ), which was found to be only moderately reactive (Supplementary Dataset 2). Comparing FH-regulated cysteines to those identified in a recent chemoproteomic study of DMF 19 , we find only a small fraction (4.2%) with R ≥ 2 overlap, providing additional evidence for the distinct reactivity of these molecules ( Supplementary Dataset 1, Fig. 2d ). A higher percentage of mitochondrial proteins were regulated by FH (41%) compared to DMF (8%), suggesting oncometabolite compartmentalization as one driver of this distinct reactivity (Supplementary Dataset 1, Fig. 2e ). Analysis of the evolutionary conservation of (i) FH-regulated cysteines, (ii) FH-insensitive cysteines (R ~1), and (iii) hyperreactive cysteines 16 revealed FH-regulated cysteines to be the least well-conserved ( Fig. 2f ). This is consistent with the hypothesis that fumarate acts as a covalent metabolite only upon hyperaccumulation, which would limit its reactivity from exerting strong evolutionary pressure. HEK-293 proteomes were treated with fumarate (0, 1, 5, and 10 mM) for 15 h before western blotting. c, Application of fumarate alkyne (FA-alkyne, 1) to visualize reactivity of the fumarate chemotype. HEK-293 proteomes were treated with FA-alkyne (0, 0.1, 0.5, and 1 mM) for 15 h before click chemistry and SDS-PAGE. d, Application of iodoacetamide alkyne (IA-alkyne, 2) as a competitive probe of covalent fumarate labeling. HEK-293 proteomes were incubated with fumarate for 15 h before treatment with 100 μ M IA-alkyne for 1 h followed by desalting, click chemistry, and SDS-PAGE. Representative images from two independent experiments are shown with Ponceau and Coomassie staining used to establish uniform protein loading in b-d. Uncropped scans of gels and immunoblots are provided in Supplementary Fig. 10 .
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Interestingly, we found that individual proteins displaying multiple FH-regulated cysteines often exhibited unidirectional changes in reactivity ( Supplementary Fig. 2a , Supplementary Dataset 1). This profile may indicate a global change in protein level 23 . Therefore, to bolster our analysis, we sought to identify proteins whose fumarate reactivity may be masked by altered protein abundance in FH −/− and FH +/+ rescue HLRCC cells ( Fig. 3 ). We performed whole-proteome (MudPIT) LC-MS/MS analyses of FH −/− and FH +/+ cells and used this data to 'correct' , or normalize, reactivity measurements ( Supplementary  Fig. 2b ). Focusing on high-confidence FH-regulated cysteines (identified in ≥ 2 experiments, s.d. ≤ 25%), we obtained robust protein abundance data (≥ 10 spectral counts) for 55% of these parent proteins (Supplementary Dataset 1). Correcting for protein abundance led to modestly revised reactivity for the majority of residues analyzed, with 325/376 (86%) showing a less than two-fold change. Normalization for abundance increased the calculated cysteine reactivity of seven proteins by ≥ 2-fold and decreased the calculated cysteine reactivity of 44 proteins by ≥ 2-fold (Supplementary Dataset 1, Supplementary  Fig. 2c,d; Fig. 3a ). To validate our LC-MS/MS identifications, we assessed a subset of targets for fumarate-competitive labeling using the clickable chemotype mimic FA-alkyne ( Fig. 3b ). Consistent with LC-MS/MS data, capture of OAT, HNRNPL, SMARCC1, and CBX5 was competed by fumarate treatment (Fig. 3c ). In contrast, the nontarget PKM1 showed no such competition. Overall, these studies demonstrate a strategy for comparing cysteine reactivity profiles between cell lines and provide an initial glimpse into the sites and stoichiometry of the fumarate-reactive proteome.
Molecular determinants of fumarate-cysteine interactions.
Next we sought to utilize our chemoproteomic data to better understand the structural determinants of oncometabolite reactivity. As an initial step, we assessed FH-regulated cysteines for the presence of linear motifs using pLogo ( Fig. 4a , Supplementary Dataset 3). Interestingly, FH-regulated cysteines showed an enrichment of acidic residues such as glutamate (E) and aspartate (D) in flanking regions. This was unexpected, as nucleophilic cysteines are typically surrounded by proximal basic residues such as lysine (K) and arginine (R), which can serve as hydrogen bond donors and help stabilize the developing negative charge of the thiolate 24 . The atypical nature of the FH-regulated motif was further supported by pLogo analysis of hyperreactive cysteine residues 16 , which demonstrated the expected enrichment of basic flanking residues ( Fig. 4b ; Supplementary Fig. 3a ). Fumarate's cysteine reactivity motif was distinct from that of DMF and HNE ( Supplementary Fig. 3a ) 19, 25 , with only MMF showing similar enrichment of acidic residues ( Supplementary Fig. 3a ). Hypothesizing that FH-regulated cysteines may possess a unique local sequence environment, we next asked how fumarate sensitivity correlated with overall cysteine reactivity. For this, we overlaid hyperreactive cysteines (identified by concentration-dependent IA-alkyne labeling) 16 onto our FHregulated map. This led to the observation that FH-regulated cysteines are strikingly anticorrelated with reactivity ( Fig. 4c ). To extend this finding, we treated HEK-293 proteomes with exogenous fumarate and used IA-alkyne analysis to define cysteine residues capable of directly reacting with fumarate ('fumarate-sensitive cysteines'; Supplementary Fig. 10 . c, FH-regulated Cys residues identified in UOK262 cells (n ≥ 2; s.d. ≤ 25%). Light/heavy ratios of cysteine reactivity are plotted for 684 high-confidence FH-regulated cysteine residues identified in FH +/+ (light) and FH −/− (heavy) cell lines. d, Overlap of FH-regulated Cys residues (R ≥ 2; n ≥ 1) with DMF-regulated Cys residues identified in Blewett et al. 19 (R ≥ 2; n ≥ 1). e, Subcellular localization of FH-regulated and DMF-sensitive Cys residues. f, Conservation of FH-regulated, FH-neutral, and hyperreactive cysteine residues identified in Weerapana et al. 16 . Peptides with the highest R values from each dataset (n = 50) were used for analysis. Data is presented as box and whiskers plot with box representing 25th-75th percentile, horizontal line representing median, and whiskers representing minimum and maximum values. Statistical significance was assessed using a Student's t-test (two-tailed, unpaired); **P < 0.01. Data for individual proteins are available in Supplementary Dataset 1 and can be searched via a web interface at https://ccr2.cancer.gov/resources/Cbl/proteomics/fumarate.
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Supplementary Dataset 4). Of the nine highly FH-regulated cysteine residues quantified in this experiment (R > 2, Supplementary Dataset 1) eight were rendered less reactive by fumarate (R > 1.5, Supplementary Dataset 4), indicating that exogenous fumarate can influence cysteine occupancy in a manner similar to FH mutation. Overlaying hyperreactive cysteines onto this fumarate dataset again identified an inverse relationship between fumarate sensitivity and cysteine reactivity ( Supplementary Fig. 3b ; Supplementary Dataset 4). In contrast, stimuli such as DMF 19 or GSNO 20 were found to target cysteine residues across the fumarate-sensitivity spectrum ( Supplementary Fig. 3c,d ). Furthermore, in proteins such as NIT2 and GSTO1 that contain nucleophilic active site cysteines, FH mutation and fumarate preferentially reduced the reactivity of distal residues ( Fig. 4d ; Supplementary Fig. 3e ). These analyses define a unique local environment for covalent oncometabolite labeling.
Fumarate is a conditionally reactive oncometabolite. To better understand the mechanistic basis for these observations, we first assessed the pK a -dependent reversibility of cysteine S-succination. We reasoned that reversible labeling of low-pK a hyperreactive cysteines may enable their irreversible capture by IA-alkyne, explaining the observed anticorrelation. To test this hypothesis, we applied a recently developed fluorescence assay to assess fumarate release from S-succinated thiols of disparate acidities ( Fig. 4e ; Supplementary Fig. 4a ,b) 26 . Although S-succinated thiols did demonstrate pK a -dependent reversibility, the extent of fumarate release was minor, with only 2-4% reversal observed over 24 h ( Fig. 4e ; Supplementary Fig. 4c ). These studies suggest that reversible S-succination can occur, but it makes an overall minor contribution to fumarate's covalent labeling profile. We next considered an alternative hypothesis: protonated hydrogen fumarate may function as the active electrophile in S-succination reactions. The plausibility of hydrogen fumarate as a reactive species has precedence in previous studies of MMF 18 and would be expected to increase fumarate's reactivity by lowering its LUMO energy ( Supplementary Fig. 4d ) and reducing repulsive electrostatic interactions with the cysteine thiolate. Consistent with this premise, we found that although IA-alkyne exhibits increased protein labeling at higher pH (presumably due to higher thiolate concentrations; Fig. 4f ), labeling of proteins by FA-alkyne and fumarate proceeds to a greater extent at lower pHs, which favor hydrogen fumarate formation ( Fig. 4f ,g; Supplementary Fig. 4e ). Analysis of S-succination kinetics using model thiols further confirmed the increased reaction rate of fumarate at acidic pH ( Fig. 4h ,i; Supplementary  Fig. 4f-h) . The second-order rate constants for S-succination of thiophenol (10 −2 to 10 −3 M −1 s −1 ) were slow relative to rates of thiol adduction measured for iodoacetamide (0.15 M −1 s −1 ) 27 , hydroxynonenal (1.2 M −1 s −1 ) 28 , and hydrogen peroxide (2.9 M −1 s −1 ) 29 , consistent with the negligible concentrations of hydrogen fumarate available for reaction at neutral pH ( Supplementary Fig. 4h ). Accelerated High  Low  CBX5_C133  PLOD1_C680  P4HA1_C528  PLEC_C317  H2AFY_C297  OAT_C150  PABPC1_C128  MYO1C_C161  DDX3X_C223  HS90AB1_C521  GLUD1_C376  PTBP1_C250  ACADVL_C477  TKT_C133  CBX3_C177  HNRPDL_C277  RPS16_C25  PYCR1_C120  EEF2_C41  NAMPT_C39  RPL23_C28  GSTP1_C48  TUBA3D_C347  NNMT_C141 Abundance corrected reactivity (calculated) ). An extended graphic of protein families harboring high confidence, abundance-corrected FH-regulated cysteine residues is provide in Supplementary Fig. 2d . b, Validating FH-regulated Cys residues using the clickable chemotype mimic FA-alkyne. c, FA-alkyne capture of proteins that contain FH-regulated Cys residues is competed by fumarate (3 h pre-incubation with 1 mM fumarate; then 15 h treatment with 100 μ M FA-alkyne). Representative images from two independent experiments are shown. Uncropped scans of immunoblots are provided in Supplementary Fig. 10 . 16 . Fifty cysteines found to be most hyperreactive were used for the analysis. c, FH-regulated Cys residues are anticorrelated with Cys-reactivity. For all 684 FH-regulated cysteine residues, only those with light/heavy ratios ~ < 2.5 had been previously annotated as hyperreactive (orange circles) in Weerapana et al. 16 . d, FH mutation preferentially modulates the reactivity of a distal Cys in NIT2 (n = 3 independent experiments). e, The reversibility of S-succinated model thiols is slow and dependent on leaving-group pK a . S-succinated thiols (1 mM 
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NATURe CHeMICAL BIOLOgy product formation at acidic pH was specifically observed with fumarate, but not DMF, presumably because the latter is a competent electrophile under neutral conditions ( Supplementary Fig. 4i ). FH-deficient HLRCC cells exhibited decreased intracellular pH relative to FH rescue and HEK-293 cells, consistent with an environment conducive to S-succination ( Fig. 4j) . These studies reveal a paradoxical influence of pH on fumarate reactivity and suggest hydrogen fumarate as a novel molecular entity responsible for covalent protein modification in HLRCC.
FH-regulated cysteines intersect kidney cancer pathways.
To identify novel biology affected by covalent oncometabolism, we performed pathway analysis of FH-regulated cysteines. To focus on S-succination events likely to functionally impact protein activity, we employed the informatics tool Mutation Assessor 30 , which uses a conservation-based analysis to estimate the probability that a mutation will alter protein function. FH-regulated cysteines were analyzed as C to E mutations to mimic the negative charge and steric bulk introduced by S-succination. Analyzing raw and abundancecorrected FH-regulated cysteines (R ≥ 2, 50% relative stoichiometry), we identified 74 proteins whose modifications were expected to have a high or moderate impact on protein function ( Fig. 5a ; Supplementary Dataset 3). Extending this workflow to lower stoichiometry FH-regulated cysteines (R ≥ 1.5) highlighted an additional 63 proteins. Gene ontology analysis found these candidate functionally S-succinated proteins clustered in pathways related to mitochondria, metabolism, RNA processing, and gene expression, many of which play known roles in kidney cancer pathogenesis ( Fig. 5b; Supplementary Dataset 3) . For mechanistic analysis we prioritized targets (1) for whom loss-of-function genetic lesions had been identified in kidney cancer patient genomes, and (2) that mapped to predicted cofactor or protein-binding sites (Fig. 5c,d) .
These analyses led us to investigate SMARCC1 as a case study to understand the functional consequences of fumarate reactivity.
Analysis of an FH-regulated cysteine in the SWI/SNF complex.
SMARCC1 is a core member of the SWI-SNF chromatin remodeling complex, a known tumor suppressor in many cancers 31 . In clear cell renal cell carcinoma (ccRCC), SMARCC1 is commonly deleted because of its position on chromosome 3, which lies adjacent to the VHL tumor suppressor. Of note, SMARCC1 does not exhibit coordinate mutation and deletion in VHL-deficient ccRCC, suggesting that an intact genomic copy of SMARCC1 is required for survival 32 .
The FH-regulated residue Cys520 (C520; Fig. 5e ) lies in SMARCC1's SWIRM domain, the most common location of SMARCC1 somatic mutation in cancer. Studies of SMARCC1's mouse ortholog (Srg3) have found that the SWIRM domain regulates the stability of SNF5, a tumor-suppressive subunit of SWI-SNF 33 . A recent crystal structure revealed that C520 lies within a solvent-exposed helix residing directly at the SMARCC1-SNF5 interface, suggesting that its modification may obstruct this protein-protein interaction (Fig. 5d ) 34 .
To test this hypothesis, we performed co-immunoprecipitation experiments in HEK-293 cells transfected with plasmids encoding FLAG-tagged SNF5 and either wild-type SMARCC1, a C520E mutant, or a C520S mutant. Mutation of C520 to an S-succination mimic (glutamate) abrogated the ability of SNF5 to capture SMARCC1 ( Fig. 5f; Supplementary Fig. 5a ). In contrast, a less obtrusive serine mutation was completely tolerated ( Supplementary  Fig. 5b) . Similarly, whereas ectopic expression of wild-type SMARCC1 stabilized SNF5, the C520E mutation had less of an effect ( Supplementary Fig. 5c ) 35 . Additionally, treatment of cells co-overexpressing SMARCC1 and SNF5 with cell-permeable ethyl fumarate also reduced SNF5 stability ( Supplementary Fig. 5d ). Analysis of HLRCC cells revealed greater labeling of SMARCC1 C520 by IA-alkyne in FH +/+ rescue as compared to FH −/− cells, consistent with covalent modification of this residue by endogenous fumarate (Fig. 5e ). FH mutation also reduced the reactivity of the homologous cysteine in SMARCC2, whose SWIRM domain is nearly identical to that of SMARCC1 ( Supplementary Fig. 5e,f) . However, direct detection of C520 S-succination proved more challenging. MudPIT analysis of FH −/− cell lines validated S-succination of several fumarate-sensitive proteins (GCLM, PCBP1, and TCP1; Supplementary Dataset 5; Supplementary Fig. 6 ), but not SMARCC1. S-succination blots of SMARCC1 immunoprecipitated from FH −/− and FH +/+ HLRCC cells were characterized by high background, with a slightly increased signal in FH-deficient cells (Fig. 5g ). To further explore this phenomenon, we next examined HLRCC cells for evidence of a disrupted SMARCC1-SNF5 interaction. Co-immunoprecipitation of the SWI-SNF complex indicated a modest decrease in SMARCC1's interaction with SNF5 in FH −/− relative to FH +/+ rescue cells (Fig. 5h ). In line with decreased interaction, SNF5 protein, but not transcript levels, are also lower in these cells ( Fig. 5h ; Supplementary Fig. 7a,b) . Though the interaction between SMARCC1 and SNF5 is weakened, it is not fully disrupted, as glycerol gradient fractionation indicates the core SWI-SNF complex remains intact ( Supplementary Fig. 8a ). HLRCC cells have a transcriptional profile consistent with SNF5 inhibition, with FH-and SNF5-dependent transcripts from published RNA-seq data sets exhibiting significant overlap (Supplementary Dataset 6; Supplementary Fig. 8b,c) . Knockdown studies indicate SNF5-dependent regulation of one of these genes is lost upon FH mutation, consistent with the hypothesis that FH activity may regulate SNF5 ( Supplementary Fig. 8d ). Finally, we examined the sensitivity of HLRCC cells to EZH2 inhibitors, whose lethality is known to be potentiated by SNF5 disruption 36 . Multiple EZH2 inhibitors exhibited FH-dependent disruption of HLRCC spheroid growth (Fig. 5i,j; Supplementary Fig. 8e ), consistent with a measurable, but minor, impact of fumarate on SNF5 function. These studies demonstrate a novel cysteine-dependent protein-protein interaction in the SWI-SNF complex that may be modulated by oncometabolite accumulation.
Proteomic ID of ligandable cysteines upregulated in HLRCC.
Although reactive metabolites are largely expected to exert negative effects on protein function 37 , as a final experiment we wondered whether our dataset may also be capable of identifying pathways activated by FH mutation. To explore this concept, we reassessed our chemoproteomic data from FH −/− and FH +/+ rescue HLRCC cell lines, focusing on FH-regulated cysteines with R values < 1 (blue region, Fig. 2c ). These residues possess greater reactivity in FH −/− cells and are expected to originate from proteins whose abundance or activity is increased by FH loss. Applying gene set enrichment analysis (GSEA) 38 to this cysteine subset identified an enrichment in proteins activated by the transcription factors HIF-1α and NRF2 (Fig. 6a ), pathways that have previously been shown to be overactive in HLRCC 4, 9, 11 . This suggests that chemoproteomic analyses may provide a useful complement to traditional methods such as gene expression for the discovery of novel cancer pathways. However, an additional feature chemoproteomics is that it also has the potential to identify leads for covalent ligands targeting these pathways (Fig. 6b ). To explore this concept, we cross referenced cysteines activated by FH mutation with a recently reported covalent fragment library whose proteome-wide targets were characterized 17 . This analysis identified ligandable cysteines in several pathways that exhibit increased IA-alkyne reactivity upon FH loss, including glycolysis, hypoxia, and reactive-oxygen stress ( Supplementary Fig. 9 ). These studies highlight a strategy for mining chemoproteomic data to identify novel targets and lead fragments for pathway disruption in HLRCC.
Discussion
The discovery of hereditary cancers driven by TCA cycle mutations provided some of the first evidence that metabolites themselves Articles NATURe CHeMICAL BIOLOgy could fuel tumorigenic signaling 1, 2 . Recent data indicates that 'oncometabolic' signaling is not unique to these contexts, but may instead represent a broader aspect of malignancy 3 . While this provides another powerful example of how studying genetic disorders can illuminate general cancer mechanisms 39 , understanding precisely how oncometabolites drive malignant transformation and developing diagnostics to track this process remain critical goals. Here we have applied chemoproteomics to define a novel complement of protein cysteines sensitive to the oncometabolite fumarate in the genetic cancer syndrome HLRCC. Competitive labeling using residues predicted to be functional using the informatics tool Mutation Assessor (R ≥ 1.5; n ≥ 2). b, Gene ontology analysis of FH-regulated Cys residues. c, Correlation between genes containing FH-regulated Cys residues and genetic alterations in kidney cancer (RCC). Statistical significance was assessed using a Student's t-test (two-tailed, unpaired); P < 0.01. d, SMARCC1 C520 lies in the SWIRM domain and is highly conserved. e, SMARCC1 C520 undergoes FH-regulated changes in occupancy in HLRCC cells (n = 3 independent experiments). f, SMARCC1 C520E mutation limits co-immunoprecipitation with SNF5 in HEK-293 cells co-overexpressing FLAG-tagged SNF5 with Myc-tagged SMARCC1. g, SMARCC1 S-succination can be detected in FH-deficient and FH WT HLRCC cell lines after IP of endogenous SMARCC1. h, SNF5 demonstrates decreased co-immunoprecipitation and decreased levels in FH −/− HLRCC cells. Left, results from SWI/SNF complex co-immunoprecipitation with BRG1 antibody. Right, endogenous levels of SWI/SNF complex members in HLRCC cells. Representative images from two independent experiments are shown in f-h. Uncropped scans of immunoblots are provided in Supplementary Fig. 10 . i, EZH2 inhibitors exhibit modest selectivity for FH-deficient HLRCC cells. UOK262 FH −/− or FH WT spheroids were treated with GSK126 (21 d; 1, 2, 4, 8, and 16 μ M) and % viability plotted relative to the vehicle treated spheroids. Data is presented as mean ± s.d.; n = 3/group. j, EZH2 inhibitors are toxic to HLRCC spheroids. UOK262 FH −/− spheroids were treated with vehicle or EPZ6438 (14 ds; 5 μ M). Figure is representative of six replicates.
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IA-alkyne facilitates the discovery of FH-regulated cysteines while circumventing the necessity for antibody generation or direct detection of poorly ionizable, negatively charged S-succinated peptides. To facilitate future applications of this resource, we have created an accessible web interface where this data may be easily browsed and queried (https://ccr2.cancer.gov/resources/Cbl/proteomics/ fumarate). Our study builds on previous proteome-wide studies of reactive lipids and oxidants 25, 40 and represents the first application of isoTOP-ABPP to study a hereditary cancer disorder driven by a reactive metabolite. In the future, we anticipate that the analyses presented here should provide a useful model for studying biological contexts marked by the production of other endogenous electrophiles including oxidized lipids 25 , itaconate 41 , and acyl-CoAs 42, 43 .
An unanticipated finding of our study was that FH-regulated cysteines demonstrate an anticorrelation with cysteine reactivity. Furthermore, fumarate reactivity is increased at acidic pH. This suggests that fumarate requires both hyperaccumulation as well as protonation to function as a covalent metabolite. In this regard HLRCC tumors constitute a 'perfect storm' for S-succination, because of their potent production of fumarate (driven by FH loss) as well as lactic acid (due to increased glycolysis) 4, 21 . Fumarate, lactate, and protein S-succination are also coordinately upregulated in diabetes and mitochondrial respiratory chain disorders 13, 44 , suggesting additional disease contexts in which this conditional reactivity may play a role. Pathway analyses led to identification of a FH-regulated cysteine in SMARCC1 that is critical for protein-protein interactions with the tumor suppressor SNF5. Interestingly, a recent histopathology study identified an FH-deficient HLRCC patient sample (1 of 31 analyzed) in which SNF5 was depressed in the absence of a mutation, leading the authors to hypothesize SNF5 may be regulated by nongenetic mechanisms in HLRCC 45 . Further study will be required to determine the prevalence of this phenomenon and its correlation with covalent S-succination of SMARCC1. Besides defining a minor contribution of fumarate to SWI-SNF dysfunction in HLRCC, our findings also illustrate the potential of covalent metabolites to regulate protein-protein interactions (PPIs) in the nucleus. FH-regulated cysteines with high R values are characterized by a large degree of surface exposure ( Supplementary  Dataset 7) , and it is tempting to speculate this may predispose them toward disruption of biomolecular interactions. Though relatively few examples of reactive metabolite-dependent PPIs exist 37 , the role of cysteine oxidation in regulating such interactions is well precedented 40, 46 . Our studies suggest that further investigation of metabolite-regulated protein-protein and protein-nucleic acid interactions may be warranted.
Finally, it is important to point out some limitations of the current study. One drawback of our competitive profiling method is that it does not directly identify S-succinated cysteines, but rather cysteines whose reactivity is altered by FH mutation. This leads to the caveat that the observed reactivity changes could be due to direct modification by fumarate or owing to reactive oxygen species that are known to be produced as a consequence of FH mutation. Therefore, an important future goal will be the development of methods for direct S-succination analysis, including immunoprecipitation-grade antibodies and/or techniques analogous to the biotin-switch protocols used to investigate other cysteine modifications 47 . In addition, our work illustrates the difficulty of differentiating between changes in reactivity and expression in FH mutant and wild-type cell lines. This issue was also encountered in a recent study of NRF2 mutant cancers 23 and illustrates the importance of integrating chemoproteomic data with whole-proteome and transcriptome analyses to provide a more complete picture of cysteine 
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NATURe CHeMICAL BIOLOgy reactivity. A final critical challenge exemplified by the current study is high-throughput validation. We identified > 100 cysteines predicted to be functionally impacted by FH mutation ( Supplementary  Dataset 3) , which exceeds the bandwidth of most laboratories for mechanistic follow-up. In the future we anticipate chemoproteomic studies of protein-metabolite interactions will benefit from marriage to orthogonal high-throughput methods, such as pooled CRISPR screening approaches 48 , to enable the rapid validation of functional oncometabolite targets. The data presented here provide an information-rich resource for such studies, and as such constitute a critical step toward defining fumarate as a signaling molecule and biomarker in HLRCC and other pathophysiological settings.
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Methods General materials and methods. Streptavidin agarose resin was purchased from Thermo Fisher Scientific (20353). Protein A/G plus agarose resin was purchased from Sigma (20423). Fumaric acid (A10976) and ethyl fumarate (A12545) were purchased from Alfa Aesar. Maleic acid (M0375), dimethyl fumarate (242926), mono-methyl fumarate (651419), and thiophenol (240249) were purchased from Sigma. Cycloheximide (14126) and EPZ6438 (16174) were purchased from Cayman Chemical. Fmoc-Cys-OH (FAA1362) was purchased from Iris Biotech. JQEZ-05 (S8607) and GSK126 (S7061) were purchased from Selleck Chemical. Anti-FLAG pulldown was performed using immunoprecipitation kit (KBA-319-383) from Rockland Immunochemicals, Inc. SDS-PAGE was performed using Bis-Tris NuPAGE gels (4-12%, Invitrogen #NP0322), and MES running buffer (Life technologies #NP0002) in Xcell SureLock MiniCells (Invitrogen) according to the manufacturer's instructions. SDS-PAGE fluorescence was visualized using an ImageQuant Las 4010 Digital Imaging System (GE Healthcare). Total protein content on SDS-PAGE gels was visualized by Blue-silver Coomassie stain, made according to the published procedure 49 . For western blotting, SDS-PAGE gels were transferred to nitrocellulose membranes (Novex, Life Technologies # LC2001) by electroblotting at 30 V for 1 h using a XCell II Blot Module (Novex). Membranes were blocked using StartingBlock (PBS) Blocking Buffer (Thermo Scientific) for 20 min, then incubated overnight at 4 °C in a solution containing the primary antibody of interest (1:3,000 dilution for S-succinated-Cys antibody and 1:1000 dilution for all other antibodies) in the above blocking buffer with 0.05% Tween 20. The membranes were next washed with TBST buffer and incubated with a secondary HRP-conjugated antibody (anti-rabbit IgG, HRPlinked; 7074, Cell Signaling, 1:1,000 dilution) for 1 h at room temperature. The membranes were again washed with TBST, treated with chemiluminescence reagents (Western Blot Detection System, Cell Signaling) for 1 min, and imaged for chemiluminescent signal using an ImageQuant Las4010 Digitial Imaging System (GE Healthcare). Fluorimetric analysis of fumarate using hydrazonyl chloride was performed on Photon Technology International QuantMaster fluorimeter using 1-cm path length, 0.13 mL quartz microcuvettes (Helma #101-015-40) at ambient temperature (22 ± 2 °C), using an excitation wavelength of 390 nm, slit width of 3.5 nm, and monitoring emission from 410 nm to 615 nm.
Cell lines, plasmids, and antibodies. HEK-293 cells were obtained from the NCI tumor cell repository. UOK262 (FH −/− ), UOK262WT (FH +/+ rescue), UOK268 (FH −/− ) and UOK268WT (FH +/+ rescue) cells were obtained from the Linehan lab 21 . Plasmids encoding FLAG-tagged SNF5, Myc-tagged SMARCC1 and Myctagged GFP were obtained as a gift from T. Archer (Epigenetics & Stem Cell Biology Laboratory, NIEHS). C520E and C520S mutations were introduced to Myc-SMARCC1 entry clone using custom oligos along with the Quick Change Site-Directed Mutagenesis Kit (Agilent #200515) and transformed into DH10B cells. The insert was fully sequenced to confirm the mutation. Transfection-quality plasmid DNA was generated using the GenElute HP Maxiprep Kit. Qubit Protein Assay kit was purchased from Life Technologies (Q33212). S-succinated-Cys antibody was kindly provided by N.F. (University of South Carolina). SMARCC1 (11956), SNF5 (8745), BRG1 (3508), PKM1 (7067), Myc-Tag (2278), FLAG-Tag (14793) and HA-Tag (3724) antibodies were purchased from Cell Signaling Technologies. OAT (A305-355A), HNRNP-L (A303-895A), CBX5 (A300-877A), EEF2 (A301-688A) and MAP2K4 (A302-658A) antibodies were purchased from Bethyl Laboratories, Inc. IP-grade antibodies for SMARCC1 (sc-32763) and BRG1 (sc-17796) were obtained from Santa Cruz Biotechnology.
Chemicals. Synthesis of compounds are described in Supplementary Note 1.
Cell culture and isolation of whole-cell lysates. HEK-293 cells were cultured at 37 °C under 5% CO 2 atmosphere in a growth medium of DMEM supplemented with 10% FBS and 2 mM glutamine. UOK262 and UOK268 cell lines were cultured in DMEM supplemented with 10% FBS, 2 mM glutamine, and 1 mM pyruvate. UOK262WT and UOK268WT cell lines were cultured in DMEM supplemented with 10% FBS, 2 mM glutamine, 1 mM pyruvate and 0.3 mg/mL of G418. Unfractionated proteomes were harvested from cell lines (80-90% confluency) by washing adherent cells 3× with ice cold PBS, scraping cells into a Falcon tube, and centrifuging (1,400 r.c.f. × 3 min, 4 °C) to form a cell pellet. After removal of PBS supernatant, cell pellets were either stored at − 80 °C or immediately lysed by sonication. For lysis, cells were first resuspended in 1-2 mL ice-cold PBS (10-20 × 10 6 cells/mL) containing protease inhibitor cocktail (1 × , EDTA-free, Cell Signaling Technology # 5871 S) and PMSF (1 mM, Sigma # 78830). These samples were then lysed by sonication using a 100 W QSonica XL2000 sonicator (3 × 1 s pulse, amplitude 1, 60 s resting on ice between pulses). Lysates were pelleted by centrifugation (14,000 r.c.f. × 30 min, 4 °C) and quantified on a Qubit 2.0 Fluorometer using a Qubit Protein Assay Kit. Quantified proteomes were diluted to 2 mg/mL and stored in 1 mg aliquots at − 80 °C for chemoproteomic or enzyme activity analyses. For the studies involving pH-dependence, cells were lysed in a lysis buffer containing 50 mM potassium phosphate buffer at specified pH, 1 mM PMSF and 1 × protease inhibitor cocktail.
Calculation of metabolite LUMO energies. LUMO energies were calculated using the program Spartan '10 as previously described 26 . Briefly, models of each metabolite or drug were drawn using the Build command. Carboxylic acid hydrogens were deleted for fumarate, mono-methyl fumarate, and hydrogen fumarate to render them as di-and monoanions as appropriate. Calculations of the ground state equilibrium geometry for each molecule were performed using the Hartree-Fock 3-21 G model in vacuum. All calculations were performed starting from the AM1 geometry, with Global Calculations and Orbitals and Energies boxes checked. LUMO energies were obtained by selecting Display and Orbital Energies and are specified in units of eV.
Gel-based detection of FA-alkyne labeled proteomes. 20 μ g proteome was incubated with specified concentration of FA-alkyne at room temperature (25 ºC) for the specified time. For competition experiments, 1 mg proteome (0.5 mL, 2 mg/mL) was pre-incubated with the competitor (1 mM) for 3 h, followed by 15 h treatment with FA-alkyne (100 μ M). Proteomes were then desalted using Illustra NAP-5 columns (GE Healthcare # 17085301) to remove unreacted reagents, and 20 μ g proteomes were used for analysis. Proteins labeled by FA-alkyne were visualized by SDS-PAGE via Cu(i)-catalyzed [3 + 2] cycloaddition with a fluorescent azide as previously reported 42 Briefly, TAMRA-azide (100 μ M; 5 mM stock solution in DMSO), TCEP (1 mM; 100 mM stock in H 2 O), Tris-(benzyltriazolylmethyl)amine ligand (TBTA; 100 μ M; 1.7 mM stock in DMSO:tertbutanol 1:4), and CuSO 4 (1 mM; 50 mM stocks in H 2 O) were sequentially added to the labeled proteome. Reactions were vortexed, incubated at room temperature for 1 h, quenched by addition of 4 × SDS-loading buffer (strongly reducing) and analyzed by SDS-PAGE. Gels were fixed and destained in a solution of 50% MeOH/40% H 2 O/10% AcOH overnight to remove excess probe fluorescence, rehydrated with water, and visualized using an ImageQuant Las4010 (GE Healthcare) with green LED excitation (λ max 520-550 nm) and a 575DF20 filter.
Chemoproteomic labeling and enrichment of FH-regulated cysteines.
For identification of FH-regulated cysteines (Supplementary Dataset 1), 2 mg of UOK262 or UOK262WT proteomes (1 mL, 2 mg/mL) were labeled with 100 µ M IA-alkyne (10 μ L; 10 mM stock in DMSO) for 1 h at room temperature. For enrichment of FH-regulated cysteines, probe-labeled proteins were then conjugated to a light (low-fumarate proteomes: vehicle (DMSO)-treated HEK-293 or UOK262WT) or heavy (high-fumarate proteomes: fumarate-treated HEK-293 or UOK262) diazobenzene biotin-azide (azo) tag by Cu(i)-catalyzed [3 + 2] cycloaddition as previously reported 20 . Briefly, azo-tag (100 μ M), TCEP (1 mM), TBTA (100 μ M), and CuSO 4 (1 mM) were sequentially added to the labeled proteome. Reactions were vortexed and incubated at room temperature for 1 h. Proteomes labeled with heavy and light azo-tags were then combined pairwise and centrifuged (6,500 r.c.f. × 10 min at 4 °C) to collect precipitated protein. The supernatant was discarded, and protein pellets were resuspended in 500 μ L of methanol (dry-ice chilled) with sonication and centrifuged (6,500 r.c.f. × 10 min at 4 °C). This step was repeated, and the resulting washed pellet was redissolved (1.2% w/v SDS in PBS; 1 mL); sonication followed by heating at 80-95 °C for 5 min was used to ensure complete solubilization. Samples were cooled to room temperature, diluted with PBS (5.0 mL), and incubated with streptavidin beads (100 μ L of 50% aqueous slurry per enrichment) overnight at 4 °C. Samples were allowed to warm to room temperature and were pelleted by centrifugation (1,400 r.c.f. × 3 min at 25 ºC), and the supernatant was discarded. Beads were then sequentially washed with 0.2% SDS in PBS (5 mL × 1), PBS (5 mL × 3) and H 2 O (5 mL × 3) for a total of seven washes. For identification of fumaratesensitive cysteines ( Supplementary Dataset 1 (S4) ), 2 mg of HEK-293 proteomes (1 mL, 2 mg/mL) were incubated with 1 mM fumaric acid (10 μ L, 100 mM stock in DMSO) or vehicle (DMSO, 10 μ L) overnight at room temperature, which was followed by labeling with 100 μ M IA-alkyne (10 μ L, 10 mM stock in DMSO) for 1 h, desalted using NAP-5 columns to remove unreacted reagents, and was further processed via click chemistry and streptavidin enrichment as noted above. An identical experiment performed using 1 mM succinic acid (10 μ L, 100 mM stock in DMSO) was used to identify and control for potential noncovalent effects of fumarate, such as metabolism or nonspecific cysteine reactivity losses occurring during the 15 h incubation. Whole-proteome protein abundance analysis. 100 µ g of UOK262 or UOK262WT proteomes (100 µ L, 1 mg/mL) were precipitated by the addition of 5 µ L 100% trichloroacetic acid in PBS, vortexed and frozen at − 80 °C overnight. Samples were thawed, and proteins were pelleted by centrifugation (17,000 r.c.f. × 10 min). Each protein pellet was washed by resuspension in acetone (500 µ L) using sonication, which was followed by centrifugation (2, 200 r.c.f. × 10 min). The supernatant was discarded, and the pellet was allowed to dry; it was then resuspended thoroughly by sonication in 30 µ L 8 M urea in PBS. Reductive alkylation was then performed by sequential addition of 70 µ L of 100 mM ammonium bicarbonate and 1.5 µ L of 1 M DTT (65 °C for 15 min) and iodoacetamide (2.5 μ L of 400 mM in H 2 O, room temperature for 30 min). Reactions were then diluted by addition of PBS (120 μ L) and tryptic digest was performed by addition of 2 μ g of Trypsin Gold and 2.5 µ L of 100 mM CaCl 2 , followed by overnight incubation at 37 °C. Trypsin was quenched by addition of 10 µ L formic acid (~5% final volume) and undigested protein was pelleted by centrifugation (17,000 r.c.f. × 20 min). Supernatant was collected and stored at − 20 °C until ready for LC-MS/MS analysis, performed using ~50 µ L of each sample. LC-MS/MS was performed as described above with a slight modification to MudPIT protocol. Here, salt pushes of 0%, 25%, 50%, 80%, and 100% were employed. Tandem MS data analysis was performed as described above, without the -modstat option applied. Spectral counting was used for calculating the UOK262WT:UOK262 protein abundance ratios for those proteins that had > 10 spectral counts in at least one of the two cell lines, and these ratios were used to correct the FH-regulated cysteine ratios wherever possible.
Bioinformatic analysis of FH-regulated cysteines.
Annotation of protein subcellular localization as well as cysteine function and conservation was generated from the Uniprot Protein Knowledgebase (UniProtKB) as described previously 52 . Analysis of linear sequences flanking FH-regulated cysteines was performed using the informatics tool pLogo, accessible at https://plogo.uconn.edu. Input sequences are listed in Supplementary Dataset 3 and were derived from the 50 cysteines found to be most FH-regulated in this study, (highest R values, n ≥ 2; s.d. ≤ 2 5%), the 50 cysteines found to be most hyperreactive 16 , DMF-sensitive 19 , MMF-sensitive 19 , and HNE-sensitive 25 in literature datasets, and the 50 cysteines found to be most sensitive to addition of exogenous fumarate Supplementary Dataset 4. Protein sequences for motif analysis were derived from their tryptic peptide sequences using Peptide Extender (https://schwartzlab.uconn.edu/pepextend). Conservation and functional impact of FH-regulated cysteines identified in chemoproteomic experiments was analyzed using the informatics tool Mutation Assessor, accessible at http://mutationassessor.org/r3. Conservation analysis depicted in Fig. 2d represents the output of the variant conservation (VC) score for the 50 cysteines found to be most FH-regulated in this study (highest L/H ratio [R] values, n ≥ 2, s.d. ≤ 25%), the 50 cysteines found to be most FH-neutral in this study (R values closest to 1), and the 50 cysteines found to be most hyperreactive in a previous chemoproteomic study performed by Weerapana et al. 16 Solvent-accessible surface area (SASA) calculations were performed using Naccess, accessible at http://www. bioinf.manchester.ac.uk/naccess/nacdownload.html. Naccess calculates atomic accessible surface areas using a previously reported method 53 in which a spherical probe with a radius of 1.4 A (equivalent to a molecule of water) is rolled over the entire Van der Waal's surface of the macromolecule. The accessible surface area is then calculated from the path traced out from the center of the spherical probe. Available PDB structures for the top 50 FH-regulated (n = 22), fumarate-sensitive (n = 20), fumarate-insensitive (n = 23), and hyperreactive 16 (n = 22) cysteine residues were used to generate data for analysis. Potential functional impact (FI) of fumarate modifications ( Fig. 5a; Supplementary Dataset 3) reflects the effect of C to E mutations on the functional impact output of Mutation Assessor. Gene ontology analysis was performed using the bioinformatics tool DAVID, accessible at http://david.ncifcrf.gov/. Output tables in Supplementary Dataset 3 reflect DAVID analysis of FH-regulated cysteines predicted to have a medium or high impact on protein function by Mutation Assessor. Candidate functional fumarate targets were assessed for cases of genomic alteration in renal cell carcinoma (clear cell and non-clear cell) using cBioPortal (http://cbioportal.org). Structural analysis of candidate functional fumarate targets known to undergo genomic alteration in renal cell carcinoma was performed using Chimera. For gene set enrichment analysis (GSEA, Fig. 6 ), R values for FH-regulated peptides were log 2 -transformed and analyzed for 1,000 permutations using the Broad Institute's javaGSEA desktop application (http://software.broadinstitute.org/gsea/downloads.jsp). For proteins in which R values were measured for more than one cysteine-containing peptide, the peptide with the greatest absolute R value was used for GSEA analysis. GSEA outputs were replotted for graphics using a variant of ReplotGSEA package, accessible at: https://github.com/PeeperLab/Rtoolbox/blob/master/R/ ReplotGSEA.R.
Validation of FH-regulated targets using FA-alkyne. 5 mg of HEK-293 proteome (2.5 mL, 2 mg/mL) was pretreated with 1 mM fumaric acid (25 μ L, 100 mM stock in DMSO) or DMSO for 3 h before incubation with 100 μ M FA-alkyne (25 μ L, 10 mM stock in DMSO) for 15 h. Proteomes were then desalted using Illustra NAP-25 columns (GE Healthcare #17085201) to remove unreacted reagents. Labeled proteomes were enriched via Cu(i)-catalyzed [3 + 2] cycloaddition with biotin-azide as described above for chemoproteomic analysis. Following the final wash, enriched resin was collected on top of centrifugal filters (VWR, 82031-256). Proteins were eluted from resin via addition of 40 μ L 1 × SDS sample buffer, followed by boiling for 10 min at 95 °C. Following repetition of the elution step, both eluents were combined, and 20 μ L of the combined eluent was loaded onto a 4-12% SDS-PAGE gel and analyzed by western blotting.
Fluorescent quantification of fumarate release from S-succinated thiols. S-succinated thiols (1 mM final concentration, 5 μ L of 20 mM stock in DMSO) were incubated in TRIS buffer (100 mM; pH 7, 7.5, and 8) at 37 °C for 24 h. After incubation, reactions were developed by treatment with equal volume of hydrazonyl chloride from Zengeya et al. 26 (150 μ M final concentration, 300 μ M stock in CH 3 CN) for 1 h at room temperature. Fluorescence produced was then measured on a Photon Technology International QuantMaster fluorimeter using a 1-cm path length and 0.13 mL quartz microcuvettes (Helma #101-015-40) at ambient temperature (22 ± 2 °C), using an excitation wavelength of 390 nm, slit width of 3.5 nm, and monitoring emission from 410 nm to 615 nm. Fluorescence emission values at 530 nm were used to calculate percent DMF released by interpolating into a standard curve of DMF reacting hydrazonyl chloride under identical conditions. Determination of pH-dependent S-succination kinetics. The influence of pH on S-succination reaction kinetics were determined using the model nucleophile thiophenol. Reactions consisted of 3 mM thiophenol (10 μ L, 60 mM stock in CH 3 CN), 15-45 mM fumaric acid (10 μ L, 1,200-300 mM stock in DMSO), 0.2 mM 7-diethylamino-4-methylcoumarin (2 μ L, 10 mM stock in DMSO), and 100 mM tris(hydroxymethyl)phosphine (THP; 5 μ L, 400 mM stock in water) in a final volume of 200 μ L PBS pH 7.2. pH was adjusted to 5.5, 6.5, 7, and 7.5, respectively using 2 M NaOH or 1 M HCl as necessary and checked with pH strips (Millipore MColorpHast pH 2.0-9.0). Reactions were initiated by addition of thiophenol (t = 0), and 10-μ L reaction aliquots were analyzed using an Agilent Technologies 1260 Infinity HPLC equipped with a Phenomenex Kinetex C18 column (2.6 μ m, 100 Angstrom, 100 × 2.1 mm inner diameter) and UV detector with monitoring at 254 nm. Solvents used were 0.1% TFA in H 2 O (Solvent A) and CH 3 CN (solvent B). Compounds were eluted at a flow rate of 0.5 mL/minute. The method used an isocratic step from 0 to 2 min with 100% A, followed by a linear gradient to 50% B over 15 min, followed by an increasing gradient with solution B until at 20 min the solvent composition was 100% solution B. DMF alkylation reaction kinetics were analyzed similarly, substituting 1 mM DMF as an electrophile. Cysteine 1 nature research | reporting summary 
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Data collection
Mass spectrometry was performed using a Thermo LTQ Orbitrap Discovery mass spectrometer coupled to an Agilent 1200 series HPLC. Chemiluminescence signal for the western blotting images were obtained using an ImageQuant Las4010 Digitial Imaging System (GE Healthcare). Fluorimetric analysis was performed on Photon Technology International QuantMaster fluorimeter or Biotek Synergy MX plate reader. HPLC analysis was performed on Agilent Technologies 1260 Infinity HPLC equipped with a Phenomenex Kinetex C18 column.
Data analysis
The tandem MS data, generated from the 5 MudPIT runs, was analyzed by the SEQUEST algorithm. MS2 spectra matches were assembled into protein identifications and filtered using DTASelect2.0. Quantification of L/H ratios were calculated using the cimage quantification package. All the graphs reported in the manuscript were generated using GraphPad Prism. Softwares and methods used for bioinformatics analyses is listed under relevant section of online methods.
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